Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Firat Aslan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Craniofacial Surgery|October 9, 2025
Surgical Indication in Thyroid Nodules ≥4 cm: Do Larger Nodules Carry Higher Malignancy and Complication Risks?Firat Aslan, Serhat Binici, Orhan Beger, et al.
The Journal of Craniofacial Surgery|January 9, 2026
Persistent and Recurrent Differentiated Thyroid Cancer: A Surgical Perspective on OverdiagnosisSerhat Binici, Firat Aslan, Emrah Dagtekin, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 25, 2024
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)Arif Akyildiz, Deniz Can Guven, Baris Koksal, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Craniofacial Surgery|October 9, 2025
Surgical Indication in Thyroid Nodules ≥4 cm: Do Larger Nodules Carry Higher Malignancy and Complication Risks?Firat Aslan, Serhat Binici, Orhan Beger, et al.
The Journal of Craniofacial Surgery|January 9, 2026
Persistent and Recurrent Differentiated Thyroid Cancer: A Surgical Perspective on OverdiagnosisSerhat Binici, Firat Aslan, Emrah Dagtekin, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 25, 2024
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)Arif Akyildiz, Deniz Can Guven, Baris Koksal, et al.
Pageof 1